Catalyst Wire Dossier Catalyst Wire Dossier

CN-105 peptide

CN-105 · Beijing Tiantan Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CN-105 peptide, covering 2024-02-13 to 2024-02-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Neuroprotective Peptide CN-105 Peptide in Patients With Acute Supratentorial Intracerebral Hemorrhage [Phase 2]

See pricing